These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 25207957)

  • 21. Plasma visfatin level in women with polycystic ovary syndrome.
    Dıkmen E; Tarkun I; Cantürk Z; Cetınarslan B
    Gynecol Endocrinol; 2011 Jul; 27(7):475-9. PubMed ID: 20586547
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of the Ala16Val MnSOD gene polymorphism with plasma leptin levels and oxidative stress biomarkers in obese patients.
    Becer E; Çırakoğlu A
    Gene; 2015 Aug; 568(1):35-9. PubMed ID: 25958349
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum visfatin levels and metabolic syndrome criteria in obese female subjects.
    de Luis DA; Aller R; Gonzalez Sagrado M; Conde R; Izaola O; de la Fuente B
    Diabetes Metab Res Rev; 2013 Oct; 29(7):576-81. PubMed ID: 23704051
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Visfatin in juvenile obesity - the effect of obesity intervention and sex.
    Krzystek-Korpacka M; Patryn E; Bednarz-Misa I; Hotowy K; Noczynska A
    Eur J Clin Invest; 2011 Dec; 41(12):1284-91. PubMed ID: 21569027
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum Levels of Visfatin and Interleukin-6 in Non-Obese Versus Obese Men with Coronary Artery Disease.
    Naz Sh; Sandhu QSh; Akhtar A; Zafar U; Khalid A; Saeed M
    J Coll Physicians Surg Pak; 2017 Feb; 27(2):71-74. PubMed ID: 28292381
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pro-inflammatory adipocytokines, oxidative stress, insulin, Zn and Cu: Interrelations with obesity in Egyptian non-diabetic obese children and adolescents.
    Habib SA; Saad EA; Elsharkawy AA; Attia ZR
    Adv Med Sci; 2015 Sep; 60(2):179-85. PubMed ID: 25827128
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Circulating visfatin in obese non-diabetic patients in relation to cardiovascular risk factors, insulin resistance, and adipocytokines: a contradictory piece of the puzzle.
    de Luis DA; Sagrado MG; Aller R; Conde R; Izaola O
    Nutrition; 2010; 26(11-12):1130-3. PubMed ID: 19211226
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of a hypocaloric diet on serum visfatin in obese non-diabetic patients.
    de Luis DA; Gonzalez Sagrado M; Conde R; Aller R; Izaola O; Romero E
    Nutrition; 2008 Jun; 24(6):517-21. PubMed ID: 18343636
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased circulating endothelial progenitor cells and anti-oxidant capacity in obstructive sleep apnea after surgical treatment.
    Lu CH; Lin HC; Huang CC; Lin WC; Chen HL; Chang HW; Friedman M; Chen CT; Tsai NW; Wang HC; Kung CT; Su YJ; Cheng BC
    Clin Chim Acta; 2015 Aug; 448():1-7. PubMed ID: 26093341
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oxidative stress and antioxidant enzyme activity in South Indian male smokers with chronic obstructive pulmonary disease.
    Arja C; Surapaneni KM; Raya P; Adimoolam C; Balisetty B; Kanala KR
    Respirology; 2013 Oct; 18(7):1069-75. PubMed ID: 23683270
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Consumption of reduced-fat products: effects on parameters of anti-oxidative capacity.
    Velthuis-te Wierik EJ; van den Berg H; Weststrate JA; van het Hof KH; de Graaf C
    Eur J Clin Nutr; 1996 Apr; 50(4):214-9. PubMed ID: 8730607
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of simvastatin treatment on plasma visfatin levels in obese women.
    Petreanu M; Eleuterio N; Bosco AA; Sandrim VC
    Gynecol Endocrinol; 2014 Aug; 30(8):577-80. PubMed ID: 24819315
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plasma visfatin concentration as a surrogate marker for visceral fat accumulation in obese children.
    Araki S; Dobashi K; Kubo K; Kawagoe R; Yamamoto Y; Kawada Y; Asayama K; Shirahata A
    Obesity (Silver Spring); 2008 Feb; 16(2):384-8. PubMed ID: 18239648
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of the adipocytokines vaspin and visfatin in vascular endothelial function and insulin resistance in obese children.
    Yin C; Hu W; Wang M; Xiao Y
    BMC Endocr Disord; 2019 Nov; 19(1):127. PubMed ID: 31771561
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum visfatin in relation to insulin resistance and markers of hyperandrogenism in lean and obese women with polycystic ovary syndrome.
    Kowalska I; Straczkowski M; Nikolajuk A; Adamska A; Karczewska-Kupczewska M; Otziomek E; Wolczynski S; Gorska M
    Hum Reprod; 2007 Jul; 22(7):1824-9. PubMed ID: 17582143
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased plasma levels of visfatin/pre-B cell colony-enhancing factor in obese and overweight patients with metabolic syndrome.
    Filippatos TD; Derdemezis CS; Kiortsis DN; Tselepis AD; Elisaf MS
    J Endocrinol Invest; 2007 Apr; 30(4):323-6. PubMed ID: 17556870
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epicardial fat thickness: relationship with plasma visfatin and plasminogen activator inhibitor-1 levels in visceral obesity.
    Malavazos AE; Ermetici F; Cereda E; Coman C; Locati M; Morricone L; Corsi MM; Ambrosi B
    Nutr Metab Cardiovasc Dis; 2008 Oct; 18(8):523-30. PubMed ID: 18083357
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum oxidative stress, visfatin and apelin in healthy women and those with premenstrual syndrome.
    Incebiyik A; Camuzcuoglu A; Hilali NG; Ulas T; Vural M; Camuzcuoglu H; Aksoy N
    J Obstet Gynaecol; 2015 Feb; 35(2):188-92. PubMed ID: 25110962
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Visfatin/PBEF/Nampt and resistin expressions in circulating blood monocytes are differentially related to obesity and type 2 diabetes in humans.
    Laudes M; Oberhauser F; Schulte DM; Freude S; Bilkovski R; Mauer J; Rappl G; Abken H; Hahn M; Schulz O; Krone W
    Horm Metab Res; 2010 Apr; 42(4):268-73. PubMed ID: 20091460
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Visfatin, low-grade inflammation and body mass index (BMI).
    Samara A; Pfister M; Marie B; Visvikis-Siest S
    Clin Endocrinol (Oxf); 2008 Oct; 69(4):568-74. PubMed ID: 18248642
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.